GoAI
Get started
Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥487

+¥1.00 · +0.21%

Aug 24, 2:37 PM JSTData delayed

7061.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Tadashi Takahashi
Listed since
Mar 27, 2019
Employees
1,108

Market position

Day range

Current ¥487

52-week range

Current ¥487

Open
¥489
Previous close
¥486
Volume
48.4K
0.56× average
Average volume
87.03K
Average daily volume
Market cap
4.12B JPY
Beta
0.54
Market reference 1
50-day average
¥552.94
-11.93% below average
200-day average
¥844.82
-42.35% below average

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends22%15%7%0%Gross margin, FY2021: 18.59%Gross margin, FY2022: 20.03%Gross margin, FY2023: 19.48%Gross margin, FY2024: 17.43%Gross margin, FY2025: 12.99%Operating margin, FY2021: 9.94%Operating margin, FY2022: 12.15%Operating margin, FY2023: 13.00%Operating margin, FY2024: 10.62%Operating margin, FY2025: 5.99%Net margin, FY2021: 4.00%Net margin, FY2022: 5.76%Net margin, FY2023: 6.91%Net margin, FY2024: 5.28%Net margin, FY2025: 1.96%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 18.59%. Gross margin FY2022 20.03%. Gross margin FY2023 19.48%. Gross margin FY2024 17.43%. Gross margin FY2025 12.99%. Operating margin FY2021 9.94%. Operating margin FY2022 12.15%. Operating margin FY2023 13.00%. Operating margin FY2024 10.62%. Operating margin FY2025 5.99%. Net margin FY2021 4.00%. Net margin FY2022 5.76%. Net margin FY2023 6.91%. Net margin FY2024 5.28%. Net margin FY2025 1.96%.

Income trends

Revenue

14.17B JPY+16.95%

Operating income

849M JPY-34.03%

Net income

278.01M JPY-56.53%
Income trends across reported periods15.56B JPY9.99B JPY4.42B JPY−1.15B JPYRevenue, FY2021: 6.02B JPYRevenue, FY2022: 7.89B JPYRevenue, FY2023: 9.87B JPYRevenue, FY2024: 12.12B JPYRevenue, FY2025: 14.17B JPYOperating income, FY2021: 598.18M JPYOperating income, FY2022: 959.32M JPYOperating income, FY2023: 1.28B JPYOperating income, FY2024: 1.29B JPYOperating income, FY2025: 849M JPYNet income, FY2021: 240.8M JPYNet income, FY2022: 454.73M JPYNet income, FY2023: 681.88M JPYNet income, FY2024: 639.58M JPYNet income, FY2025: 278.01M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 6.02B JPY. Revenue FY2022 7.89B JPY. Revenue FY2023 9.87B JPY. Revenue FY2024 12.12B JPY. Revenue FY2025 14.17B JPY. Operating income FY2021 598.18M JPY. Operating income FY2022 959.32M JPY. Operating income FY2023 1.28B JPY. Operating income FY2024 1.29B JPY. Operating income FY2025 849M JPY. Net income FY2021 240.8M JPY. Net income FY2022 454.73M JPY. Net income FY2023 681.88M JPY. Net income FY2024 639.58M JPY. Net income FY2025 278.01M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue14.17B JPY12.12B JPY9.87B JPY7.89B JPY6.02B JPY
Cost of goods sold12.33B JPY10B JPY7.95B JPY6.31B JPY4.9B JPY
Gross profit1.84B JPY2.11B JPY1.92B JPY1.58B JPY1.12B JPY
Selling, general, and administrative525.88M JPY425M JPY344M JPY383.12M JPY342.95M JPY
Operating expenses991.96M JPY825.26M JPY639.82M JPY621.64M JPY520.86M JPY
Interest income2.29M JPY250K JPY17K JPY13K JPY9K JPY
Interest expense462.49M JPY431.58M JPY350.59M JPY282.89M JPY205.9M JPY
Depreciation and amortization584.01M JPY531.59M JPY411.74M JPY336.76M JPY228.61M JPY
Operating income849M JPY1.29B JPY1.28B JPY959.32M JPY598.18M JPY
Net income278.01M JPY639.58M JPY681.88M JPY454.73M JPY240.8M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
10.36

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates28.1516.945.73-5.48Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 25.83, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 13, 2025: actual 24.55, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 9, 2025: actual 6.59, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 13, 2025: actual 7.2, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 22.44, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual -3.16, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 9.43, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 10.36, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates4.58B4.07B3.57B3.06BQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 13, 2025: actual 3.24B JPY, estimate 3.8B JPY, surprise -14.71%, Miss. Q2 2025, reported May 9, 2025: actual 3.24B JPY, estimate 3.72B JPY, surprise -13.01%, Miss. Q3 2025, reported Aug 13, 2025: actual 3.46B JPY, estimate 4.4B JPY, surprise -21.48%, Miss. Q4 2025, reported Nov 14, 2025: actual 3.67B JPY, estimate 3.91B JPY, surprise -6.11%, Miss. Q1 2026, reported Feb 13, 2026: actual 3.81B JPY, estimate 4.24B JPY, surprise -10.19%, Miss. Q2 2026, reported May 15, 2026: actual 3.82B JPY, estimate 4B JPY, surprise -4.58%, Miss. Q3 2026, reported Aug 14, 2026: actual 3.79B JPY, estimate 3.88B JPY, surprise -2.47%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 3.7B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥25.00

2025 complete year+66.7% since 2024

Corporate action history

DividendUpcoming

Ex-dividend Dec 29, 2026

¥25.00

Annual

Record Dec 31, 2026 · Payment Dec 29, 2026

Dividend

Ex-dividend Dec 29, 2025

¥25.00

Annual

Record Dec 31, 2025 · Payment Mar 27, 2026

Dividend

Ex-dividend Dec 27, 2024

¥15.00

Annual

Record Dec 31, 2024 · Payment Mar 27, 2025

7061.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

Continue in GoAI

Research 7061.T

research.disclaimer